Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Randy Vogenberg

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
P & T : a Peer-Reviewed Journal for Formulary Management|May 9, 2017
PBM P&T Practices: The HEAT Initiative Is Gaining MomentumMartha M Rumore, F Randy Vogenberg
Biotechnology Healthcare|February 12, 2013
Biotech injectable drugs: clinical applications and financial effectsF Randy Vogenberg, Coleen Young, Debbie Liebeskind
P & T : a Peer-Reviewed Journal for Formulary Management|December 9, 2010
Personalized medicine: part 2: ethical, legal, and regulatory issuesF Randy Vogenberg, Carol Isaacson Barash, Michael Pursel
P & T : a Peer-Reviewed Journal for Formulary Management|May 3, 2018
Sterile Compounding Needs Risk Management: Access, Reconstitution Or Preparation, and AdministrationDawn G Holcombe, Rita Marcoux, F Randy Vogenberg
Biotechnology Healthcare|April 6, 2012
The biologic finance and access council 2nd annual biologics healthcare survey: views from key healthcare stakeholders, part 2David B Nash, Michael Toscani, F Randy Vogenberg
P & T : a Peer-Reviewed Journal for Formulary Management|November 2, 2010
Personalized medicine: part 1: evolution and development into theranosticsF Randy Vogenberg, Carol Isaacson Barash, Michael Pursel
Biotechnology Healthcare|April 6, 2012
The biologic finance and access council 2nd annual biologics healthcare survey: views from key healthcare stakeholdersDavid B Nash, Michael Toscani, F Randy Vogenberg
P & T : a Peer-Reviewed Journal for Formulary Management|January 4, 2011
Personalized medicine: part 3: challenges facing health care plans in implementing coverage policies for pharmacogenomic and genetic testingF Randy Vogenberg, Carol Isaacson Barash, Michael Pursel
P & T : a Peer-Reviewed Journal for Formulary Management|January 17, 2017
Systemic Market and Organizational Changes: Impact on P&T CommitteesF Randy Vogenberg, Rita Marcoux, Martha M Rumore
Journal of Occupational and Environmental Medicine|June 15, 2007
Employer benefit design considerations for the era of biotech drugsF Randy Vogenberg, John P Holland, Debbie Liebeskind
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
P & T : a Peer-Reviewed Journal for Formulary Management|May 9, 2017
PBM P&T Practices: The HEAT Initiative Is Gaining MomentumMartha M Rumore, F Randy Vogenberg
Biotechnology Healthcare|February 12, 2013
Biotech injectable drugs: clinical applications and financial effectsF Randy Vogenberg, Coleen Young, Debbie Liebeskind
P & T : a Peer-Reviewed Journal for Formulary Management|December 9, 2010
Personalized medicine: part 2: ethical, legal, and regulatory issuesF Randy Vogenberg, Carol Isaacson Barash, Michael Pursel
P & T : a Peer-Reviewed Journal for Formulary Management|May 3, 2018
Sterile Compounding Needs Risk Management: Access, Reconstitution Or Preparation, and AdministrationDawn G Holcombe, Rita Marcoux, F Randy Vogenberg
Biotechnology Healthcare|April 6, 2012
The biologic finance and access council 2nd annual biologics healthcare survey: views from key healthcare stakeholders, part 2David B Nash, Michael Toscani, F Randy Vogenberg
P & T : a Peer-Reviewed Journal for Formulary Management|November 2, 2010
Personalized medicine: part 1: evolution and development into theranosticsF Randy Vogenberg, Carol Isaacson Barash, Michael Pursel
Biotechnology Healthcare|April 6, 2012
The biologic finance and access council 2nd annual biologics healthcare survey: views from key healthcare stakeholdersDavid B Nash, Michael Toscani, F Randy Vogenberg
P & T : a Peer-Reviewed Journal for Formulary Management|January 4, 2011
Personalized medicine: part 3: challenges facing health care plans in implementing coverage policies for pharmacogenomic and genetic testingF Randy Vogenberg, Carol Isaacson Barash, Michael Pursel
P & T : a Peer-Reviewed Journal for Formulary Management|January 17, 2017
Systemic Market and Organizational Changes: Impact on P&T CommitteesF Randy Vogenberg, Rita Marcoux, Martha M Rumore
Journal of Occupational and Environmental Medicine|June 15, 2007
Employer benefit design considerations for the era of biotech drugsF Randy Vogenberg, John P Holland, Debbie Liebeskind
Pageof 9